Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.32 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13615895 | 0.91 | CYP1A2 (0.34) | ACHE | |
| SCHEMBL13615927 | 0.91 | CYP1A2 (0.34) | ACHE | |
| SCHEMBL13615738 | 0.91 | CYP1A2 (0.34) | ACHE | |
| SCHEMBL12405291 | 0.82 | HPRT1 (0.36) | ACHENR1H2NR1H3 | |
| SCHEMBL12278290 | 0.77 | HPRT1 (0.36) | ACHENR1H2NR1H3 | |
| SCHEMBL12260018 | 0.77 | HPRT1 (0.36) | ACHENR1H2NR1H3 | |
| SCHEMBL12405227 | 0.77 | HPRT1 (0.36) | ACHENR1H2NR1H3 | |
| SCHEMBL3280951 | 0.75 | ACHE (0.32) | ACHENR1H2NR1H3 | |
| SCHEMBL13615820 | 0.75 | TRIM58 (0.35) | — | |
| SCHEMBL12269011 | 0.73 | ALDH1A1 (0.41) | ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090273278-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090273278-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OCIAD1, OCIAD2, ORMDL3 | ACHE 827/4885NR1H2 264/4885NR1H3 320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.